Patent Law | Expert Legal Commentary

January 13, 2009

Egyptian Goddess v. Swisa: No more Point of Novelty Test for Design Patent Infringement

Egyptian Goddess v. Swisa

By Olivier A. Taillieu of Zuber & Taillieu LLP and Spyros J. Lazaris

In its highly anticipated en banc opinion in Egyptian Goddess v. Swisa, 543 F.3d 665 (Fed. Cir. 2008), the Court of Appeals for the Federal Circuit rejected the point of novelty test for design patent infringement. The Court held that the “ordinary observer” test set forth in Gorham v. White is the only appropriate test for assessing claims of design patent infringement. When properly applied, the “ordinary observer” test takes into account prior art; therefore, the point of novelty test was an unnecessary and inconsistent departure from precedent and common sense.

About the Author

Olivier A. Taillieu is a Partner of Zuber & Taillieu LLP, focusing on intellectual property litigation and arbitration.

Image Credit: Egyptian Goddess v. Swisa/ U.S. Court of Appeals for the Federal Circuit 543 F.3d 665 (Fed. Cir. 2008)

1 The court described its briefing request this way: “This court granted rehearing en banc and asked the parties to address several questions, including whether the “point of novelty” test should continue to be used as a test for infringement of a design patent; whether the court should adopt the “non-trivial advance test” as a means of determining whether a particular design feature qualifies as a point of novelty; how the point of novelty test should be administered, particularly when numerous features of the design differ from certain prior art designs; and whether district courts should perform formal claim construction in design patent cases.” 543 F.3d at 670.

Link Link to this Article
Link Share this Article
E-mail Email this Article
Print Printable Version (in new window)
View a PDF of the judicial opinion

Connect on Linkedin®

Olivier A. Taillieu

Companies Mentioned

Dror Swisa

Egyptian Goddess, Inc.

Swisa, Inc.

More Updates

Patent Law Updates
Advertise with LawUpdates.com

Companies Mentioned

Patent Law

The following companies are mentioned in Patent Law Updates:

Boston Scientific Corp.

Microsoft Corp.

Cordis Corp.

Boston Scientific Scimed, Inc.

U.S. Patent and Trademark Office

Samsung Electronics America, Inc.

Stryker Corp.

Stryker Sales Corp.

Teva Pharmaceuticals USA, Inc.

Glamourmom LLC

Audiovox Communications Corp.

Stryker Orthopaedics

Target Corp.

McKesson Information Solutions, Inc.

Howmedica Osteonics Corp.

Kohl’s Department Stores, Inc.

Bridge Medical, Inc.

J.C. Penney Company, Inc.

Smith & Nephew, Inc.

Cohesive Technologies, Inc.

Waters Corp.

Elizabeth Lange LLC d.b.a. Liz Lange Maternity

LG Electronics, Inc.

Quanta Computer, Inc.

Federated Department Stores

Egyptian Goddess, Inc.

Swisa, Inc.

K-Mart Corp.

Motorola, Inc.

Dror Swisa

Sears Holding Corp.

Ranbaxy, Inc.

Nokia, Inc.

SmithKline Beecham Corp. d.b.a GlaxoSmithKline

SmithKline Beecham PLC

Sanyo North America Corp.

Glaxo Group Limited d.b.a. GlaxoSmithKline

Scimed Life Systems Inc.

Smithkline Beecham Corp. (d.b.a. GlaxoSmithKline, plc.)

Johnson & Johnson, Inc.

United States Patent and Trademark Office

HT Window Fashion Corp.

Mylan Laboratories, Inc.

Mylan Pharmaceutical, Inc.

Ortho-McNeil Pharmaceutical, Inc.

Acumed, LLC

C Change Surgical LLC

SEB S.A.

Mars Electronics International, Inc.

Datascope Corp.

Additional Resources

Patent Law